Overview
Rickettsia species are obligate intracellular, Gram-negative bacteria that cause a group of potentially life-threatening diseases known as rickettsioses, including Rocky Mountain spotted fever, epidemic typhus, murine typhus, and Mediterranean spotted fever. Unlike most organisms covered in microbiome research, Rickettsia species are not constituents of the human microbiome. Instead, they are transmitted exclusively through arthropod vectors including ticks, fleas, lice, and mites. Once transmitted to humans, these bacteria target vascular endothelial cells, causing disseminated vasculitis that is responsible for the diverse clinical manifestations of rickettsial diseases.
Classification
Rickettsia belongs to the phylum Pseudomonadota, class Alphaproteobacteria, order Rickettsiales, and family Rickettsiaceae. The genus is broadly divided into two pathogenic groups. The Spotted Fever Group (SFG) includes R. rickettsii (Rocky Mountain spotted fever), R. conorii (Mediterranean spotted fever), and R. akari (rickettsialpox), which share conserved OmpA and OmpB surface proteins. The Typhus Group (TG) includes R. prowazekii (epidemic typhus, transmitted by body lice) and R. typhi (murine typhus, transmitted by fleas). Evolutionary analysis indicates that Rickettsia species have undergone extensive genome reduction as a consequence of their obligate intracellular lifestyle.
Key Characteristics
The hallmark of rickettsial pathogenesis is the invasion and multiplication within vascular endothelial cells lining small-to-medium blood vessels throughout the body. OmpB, conserved across all Rickettsia species, serves as the major surface cell antigen and adhesin for host cell attachment. Once internalized, the bacteria escape from the phagosome and replicate freely in the host cell cytoplasm. The resulting vasculitis can affect virtually any organ system, producing symptoms ranging from fever and headache to severe manifestations including encephalitis, pulmonary edema, and organ failure. Protective immunity requires both CD4+ and CD8+ T cells along with interferon-gamma, while severe disease has been associated with elevated IL-10-producing regulatory T cells that suppress effective immune responses.
Health Significance
Rickettsial diseases represent a significant global health concern, particularly in endemic regions and among travelers. Rocky Mountain spotted fever, caused by R. rickettsii, carries a mortality rate of approximately 20% if left untreated, making early recognition and treatment critical. Doxycycline is the first-line treatment for all rickettsial infections and should be initiated within five days of symptom onset for optimal outcomes in RMSF. While Rickettsia species are not part of the human microbiome and do not appear on gut or skin microbiome testing panels, they are included here for completeness as significant human bacterial pathogens. Interestingly, research into arthropod vector microbiomes has revealed that the composition of the tick or flea microbiome may influence the transmission efficiency and virulence of Rickettsia species, providing an unexpected connection between microbiome science and vector-borne disease. Diagnosis relies on serological testing, PCR, and clinical presentation in the context of arthropod exposure history.